The Joint Programming Initiative on Antimicrobial Resistance, JPIAMR, is a global collaborative organisation and platform, engaging 27 nations to curb antibiotic resistance (AMR) with a One Health approach. JPIAMR adds new countries as members continuously. To date JPIAMR has supported 62 projects, over 340 research groups, with funding of approximately 67 million Euro.
The JPIAMR coordinates national public funding to support transnational AMR research and activities within the six priority areas of the shared JPIAMR Strategic Research Agenda – therapeutics, diagnostics, surveillance,transmission, environment and interventions.
The challenge – lives are at stake
- Antibiotic resistance is a One Health issue, spreading between humans, animals and the environment.
- Resistance to antibiotics is increasing on a global scale.
- Limited treatment options affect modern medicine and by 2050 annual deaths due to AMR are
projected to be 10 million worldwide.
Antibiotics have saved millions of lives throughout the many decades it has been in use as a common drug. However, antibiotic resistance is now a global health security challenge. When bacteria become resistant to commonly used drugs, society needs to respond with concerted actions. Only together can we divert from a trajectory leading to up to 10 million human lives being extinguished yearly because of antibiotic resistant bacteria, this by 2050 if projections becomes reality. Collaboration is the cornerstone of JPIAMR and collaboration is key – resistant bacteria knows of no nations boarders. Currently, there are few new antibiotics in development and we need to find ways to curb AMR now.
Find Facts on AMR
WHO: Facts on AMR
The Future – global collaboration creates transformative changes
The mission for JPIAMR for the years 2020-2025 is stated as: “To join forces across nations by leading the alignment, coordination, and support to Antimicrobial Resistance One Health collaborative research and global policy activities”.
The overarching major goals are:
- To align national and international research programmes.
- To support and coordinate transformative research.
- To support and coordinate the JPIAMR Virtual Research Institute.
- To promote innovation and translation of research results.
- To bridge the gap between research and policy.
JPIAMR support new evidence and innovations that reduce the burden of antimicrobial resistance through coordinated global collaborative research in Europe and around the world. Also aiming to undertake further research to better understand how resistance develops and spreads in the environment. And to develop diagnostic tools and better surveillance methods as well as validating smarter strategies for using antibiotics in healthcare and agriculture.
JPIAMR will contribute to faster global progress of research and innovation on antimicrobial resistance. To ultimately find new cures and methods to harness drug resistant bacteria. The Virtual Research Institute is a dynamic network of research facilities and research capabilities, changing the way resources are shared and used.
The scientific and societal challenge of AMR is likely to be greater in the next 10 years.
JPIAMR is the key to turn the tide of AMR in Europe and beyond.
The Secretariat of JPIAMR is hosted by the Swedish Research Council in Stockholm, Sweden.